Name | Title | Contact Details |
---|
Capital Health Plan is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
B&W Handicap Equipment is a Fayetteville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BTG is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins. Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare. As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter. We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago. We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems. With relentless curiosity we`ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.
Amkai is a Armonk, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.